Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Wishing our readers a very Happy New Year 2022!!!
Welcome to yet another most pleasant Reading of our newsletter.
It is always my privilege to reach you on 1st & 17th of every month, since the last 11 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
India’s approach to fighting the pandemic will always remain science based. We are also augmenting health infrastructure to ensure our fellow citizens get proper care.
Let us keep following all COVID-19 related protocols and overcome the pandemic.
Narendra Modi
Prime Minister
Government of India
Sponsor
Patient Safety Capsules
Personalised medicine could offer promising results in healthcare, says report
New Delhi, January 12, 2022: Personalized medicine is fast becoming the most promising new field in medical science and advancements in technologies such as artificial intelligence (AI) and genetic sequencing, developments in wearables, etc. could help to attain more results in future, says a latest report.
DCGI raises alarm over suspected spurious tocilizumab injections in India
New Delhi, January 11, 2022: The Drugs Controller General of India (DCGI) has asked the State drug controllers, zonal offices of Central Drugs Standard Control Organisation (CDSCO), and the drug manufacturers in the country to keep a watch and vigil on the activities of distribution and sale of suspected spurious tocilizumab injections, one of the medicines used for management of Covid-19, in the country.
Drug Laws & Policy Injections
DGFT imposes restriction on export of anticoagulant enoxaparin & intra-venous immunoglobulinMumbai, January 11, 2022: Amid the rising cases of Covid-19 and Omicron variant in the country, the Directorate General of Foreign Trade (DGFT) has imposed restriction on export of anticoagulant enoxaparin and intravenous immunoglobulin (IVIG) active pharmaceutical ingredients and their formulations to ensure their adequate supply in the domestic market.
BIS notifies new standard for active implantable medical devices for hearing impairment New Delhi, January 13, 2022: The Bureau of Indian Standards (BIS) has notified establishment of the revised ISO standard for active implantable medical devices part 7 particular requirements for cochlear and auditory brainstem implant systems from the date of December 27, 2021.
JAC leaders question the intent of drug control officials on not implementing the Pharmacy Act in TelanganaHyderabad, January 12, 2022: The Pharmacists Association Joint Action Committee (JAC) leaders in Telangana are annoyed over the attitude of some of the officials from the drug control administration and questioned the intent of these officers in not implementing Rule 65 (2) of Pharmacy Act as directed in the circular released by the Director General of Drug Controller recently.
PM Modi stresses on vaccination, localised measures to contain Covid without affecting livelihoodNew Delhi, January 13, 2022: Prime Minister Narendra Modi on Thursday interacted with chief ministers over the COVID-19 situation in the country and stressed on local containment of the virus spread as well as ensuring minimum damage to livelihood while making strategies to deal with the surge in cases due to the Omicron variant.
Why ICMR does not recommend Molnupiravar despite getting approval for useNew Delhi, January 7, 2022: Days after molnupiravir, an antiviral drug, was approved for use for Covid-19 patients, the Indian Medical of Medical Research (ICMR) has kept the medicine out of the treatment protocol.
SEC meets again to determine the full market nod of Covaxin and CovishieldJanuary 15, 2022: The Subject Expert Committee (SEC), an organization under the Directorate General of Drug Control (DCGI) in India, was submitted by the Bharat Biotech and Serum Institute of India for full market approval of their respective Covid vaccines (Covaxin and Covishield).
Pharma Injections
MP drug makers to install PNG run boilers to improve air quality of IndoreMumbai, January 14, 2022: In a bid to improve air quality of Indore, which is the industrial hub of Madhya Pradesh, the city administration has urged drug manufacturers to install piped natural gas (PNG) run boilers at their units.
Indian nutraceutical industry makes headway to combat malnutrition and chronic illnessBengaluru, January 15, 2022: Indian nutraceutical market is making strategic inroads to positions itself to be able to combat malnutrition and chronic illness.
DGCI will review applications for full market approval of Covaxin and Covishield New Delhi, January 14, 2022: The Subject Experts Committee, led by India’s Drug Controller General (DCGI), will consider applying for Bharat Biotech and SII on Friday for full market approval for Covaxin and Cobishield.
Studies have shown that cannabis compounds can prevent COVID-19 January 14, 2022: Researchers in the United States have discovered that cannabis compounds have the ability to prevent the virus that causes Covid-19 to invade human cells.
WHO recommends 2 new Covid-19 drugs; check their use, availability and efficacy January 15, 2022: Amidst the reeling onslaught of Omicron variant across the world, in its latest Covid-19 guideline, the World Health Organization (WH0) has recommended two new drugs namely baricitinib and sotrovimab to treat Coronavirus pa-tients.
Covaxin booster jab neutralises Omicron, Delta: Bharat Biotech January 13, 2022: Vaccine maker Bharat Biotech’s Covaxin booster shot can neutralise both Omicron and Delta variants of SARS-CoV-2 virus, a study has shown.
Drug Dopes
Once in a lifetime COVID pandemic has reaffirmed importance of health sector, says PM ModiJanuary 13, 2022: Prime Minister Narendra Modi on Wednesday inaugurated 11 government medical colleges in Tamil Nadu and said the future will belong to societies that invest in healthcare. 
Delhi govt’s online yoga classes begin for Covid patients in home isolationNew Delhi, January 12, 2022: Delhi Health Minister Satyendar Jain announced that the city government’s online yoga classes for coronavirus patients in home isolation kicked off on Wednesday.
AMMOI highlights ‘Ayurveda Aahar’ project to prevent chronic lifestyle diseases Chennai, January 13, 2022: The Ayurveda Medicine Manufacturers Organisation of India (AMMOI) has prepared a strategy based programme to highlight the ‘Ayurveda Aahar’ (Ayush based diet and lifestyle) being promoted by the Union Ministry of Ayush in order to prevent certain chronic lifestyle diseases like diabetes, obesity, hypertension, hypercholesterolemia and other diseases like sterility, pallor, cancer and heart diseases.
SIT raids 16 medical shops at Srivilliputhur in south Tamil Nadu for violation of Rule 65 (9) (a) of D&C Act Chennai, January 12, 2022: Tightening the noose around medical shops who sell medicines without valid prescriptions, a surprise raid was conducted in 16 medical shops in Srivilliputhur in Viruthunagar district in southern Tamil Nadu by the Special Investigation Team (SIT) formed by the director of the state drugs control department.
The FDA will begin collecting data on antigen home test kits set to publish advisories PUNE, January 14, 2022: The Food and Drug Administration (FDA) has requested registered pharmacists to update sales, purchase, and inventory records of antigen home testing skills against the backdrop of state governments expressing concerns about district and civil administration. did. Unregulated use and unreported cases impair community communication.
India’s new COVID-19 regulation aims to free resources but with risksNew Delhi, January 13, 2022: India has relaxed the COVID-19 rules for testing, quarantine and hospitalization to free up resources for the poorest. This strategy carries the risk of undercounting infections and deaths, but is welcomed by experts.
National Injections
Odisha Activates Telemedicine Services for Non-Covid Patients Bhubaneswar, January 13, 2022: With the proliferation of coronavirus cases, the Orissa government has allowed non-COVID patients to enable their telemedicine services, given the risk of access to hospital medical facilities. The state government issued an order on Thursday calling on the telemedicine platform to provide telemedicine assistance to the poor.
India’s Covid vaccination drive was completed in one year and so far more than 156.76 cr have been administeredNew Delhi, January 16, 2022: The national vaccination drive for COVID-19 on Sunday was completed in one year, during which time more than Rs. 15.676 billion were vaccinated. More than 92% of the adult population have been vacci-nated at least once, and more than 68% have been fully vaccinated, according to health ministry officials.
Kerala DCA writes to NPPA to bring erythropoietin injection under price control Chennai, January 15, 2022: Following a series of raid conducted in 23 discount medical shops in Manjeri Taluk in Malappuram district in Kerala, the state drugs control department has written to the national pharmaceutical pricing authority (NPPA) to bring erythropoietin injection, used for kidney patients, under price control.
Century old Nizamia Tibbi Unani Hospital in Hyderabad soon to get a major facelift Hyderabad, January 15, 2022: The century old Nizamia Tibbi Unani Medical College Hospital in Hyderabad is soon going to get a major facelift, as the Telangana health minister T Harish Rao has assured all the support and necessary funding from the government for the upliftment of the only existing Nizam era Medical College Hospital in the entire state of Telangana.
Severe staff crunch hits supervision of medical shops across Telengana Hyderabad, January 13, 2022: Telangana state is facing severe shortage of drug inspectors and pharmacy inspectors in the state because of which the state Drug Control Administration (DCA) is failing in its duties to conduct regular supervision of the medical shops and drug stores in the state.
Kerala Health Minister warns of spike in cases within three weeks January 15, 2022: Kerala Health Minister Veena George on Saturday said the COVID clusters in the state were increasing and warned that there are chances of a rapid spread of coronavirus within the next three weeks. George, who met the media here, said there are currently 78 COVID clusters in the state. “There are chances that within the next three weeks, the COVID-19 cases in the state will witness a major spike. There is a chance of rapid spread of the virus in the state. Every day, the COVID-19 cases are increasing in the state. There are Delta, Omicron variants on top of that,” George said.
Global Injections
Beijing reports first local omicron case ahead of OlympicsJanuary 16, 2022: Beijing has reported its first local omicron infection, according to state media, weeks before the Winter Olympic Games are due to start. The infected person lives and works in the city’s northwestern district of Haidian and had no travel history outside of Beijing for the past two weeks. The individual experienced symptoms on Thursday and was tested on Friday for COVID-19, officials said in a news conference Saturday during which they confirmed the infection.
Singapore based ABC World Asia has invested Rs 112 in health tech companies HCAHNew Delhi, January 14, 2022: Healthtech company HCAH (HealthCare at HOME) has raised 112 chlores from Singapore-based private equity fund ABC World Asia (“ABC”) to build a hospital healthcare delivery platform. HCAH aims to use this investment for physical rehabilitation and recovery through home ICU service coverage,
U.S. Supreme Court blocks Biden’s vaccine or testing obligations on businesses
Washington, January 13, 2022: US Supreme Court hit President Joe Biden on Thursday, blocking his Covid vaccine or testing mission against large corporations. In the split ruling, the State Supreme Court allowed healthcare workers in federal-funded facilities to pro-ceed with mandatory vaccines.
Almost All Teens in ICU With COVID Were Unvaccinated: Study
January 14, 2022: Nearly all teenagers admitted to intensive care units because of COVID-19 were unvacci-nated, according to a new study published in TheNew England Journal of Medicine.
Red Cross Declares National Blood Crisis
January 12, 2022: The Red Cross has declared a national blood crisis and is encouraging the public to donate, saying his-torically low blood supplies are causing some hospitals to change treatments and cancel surgeries.
Pfizer's Cibinqo snags FDA approval to challenge Sanofi and Regeneron's Dupixent in eczema
Janaury 12, 2022: Friday, the FDA approved the New York drugmaker's oral daily JAK1 inhibitor Cibinqo to treat adults with moderate to severe atopic dermatitis who have not been able to get their disease under control with other medicines including biologics and for those who can't take other treatments.
PSAIIF PILL
India’s R value dropped to 2.2 between January 7th and 13th, indicates IIT Madras Analysis
Chennai, January 16, 2022: According to a preliminary analysis by IIT Madras, India’s “R-value”, which indicates the rate of spread of COVID-19, was recorded at 2.2 between January 7 and 13, a decrease from the past two weeks.
Covid propels need for Union govt to consider medical expenditure and insurance premium deduction
Bengaluru, January 13, 2022: Covid-19 pandemic has stirred a hornet’s nest where rising medical expenditure and insurance premiums are proving to be a big blow to the patients. In view of the pandemic, which is threatening to become an endemic, the insurance companies have increased the premium quietly and therefore the deduction has to be appropriately increased for all segment of the working population, said A Ganesan, group vice chairman, Neuberg Diagnostics.
Frequently Asked Questions
What India learned from last year’s 2nd Covid Wave. How it is used?
On May 7, 2021, India reported a Covid-19 case of Rs 414,000. This is the maximum number of cases recorded in the second wave of the day. The overwhelming health infrastructure suffered from oxygen supply, labor shortages, narcotics and beds. The vicious second wave caused by the delta variant of SARS-CoV-2 has hurt India. Read More>>>
SUBSCRIBER'S SYMPTOM
Regular health checks are needed to maintain heart health
January 15, 2022: Heart failure is a gradual weakening of the heart muscle that is often confused with a heart attack. People proudly say they have never visited a doctor in their 70 years of life. This common mistake made by the vast majority of people, which could have been treated with small interventions, now results in a delay in diagnosing illnesses that may require surgery. It is estimated that there are about 8 to 10 million heart failure patients in the country with a mortality rate of over 20%. In India, patients are 10 years younger than the world average.
Consumer Online Foundation: The first and only organisation certified as per international standard ISO 9001:2015 for Consumer Complaint Redressal Services
First and the only organization in India to be certified on 21st September 2021 as an ISO 9001:2015 on Consumer Complaint Redressal Services. We are proud to share our achievements with our readers and supporters. Thanks for your continued support and guidance for more than 35+ years of service to the consumers in India and abroad.
Blog Addicts
Mr. Pankaj Yadav, Medical Student, Tweets: Thank you @PSAI for bringing us such amazing newsletters, so professionally edited and illu-strated perfectly … I’m a huge fan of yournewsletter
Dr. Deepika Thakur, Physician, Says:I just want to take the opportunity to thank you for doing such a wonderful job of promoting awareness regarding patient safe medicines across the country.
Dr. Jagdish Desai, Journalist, Says:
You and your entire staff demonstrated the utmost professionalism, skill and courtesies during the entire production of the newsletters. I congratulate your entire team on a job well done.
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
